Teva's Weltruza Seen as Launch-Execution Story After Clean Label, Oppenheimer Says
MT newswire2026/10/09 16:5212:52 PM EDT, 10/09/2026 (MT Newswires) -- Teva Pharmaceutical Industries' (TEVA) Weltruza approval removes the label risk that defined the long-acting olanzapine debate, leaving launch execution as the key question, Oppenheimer said in a note Friday. With no REMS, no post-injection observation requirement and no boxed warning for post-injection delirium sedation syndrome, Weltruza is the first practical olanzapine LAI, the firm said. Oppenheimer expects a quiet first half of 2027 focused on sampling, hospital formularies and state-by-state Medicaid additions, with meaningful revenue in the second half. It said the launch should be judged on samples, formulary wins and prescriptions, not early sales. The $3,950 monthly list price, 47% above Oppenheimer's initial assumption, signals Teva's confidence in the profile, the firm said. It assumes a 40% gross-to-net discount and flagged rebate depth as the key variable through 2027. Oppenheimer raised its price target to $52 from $50 and reiterated its outperform rating. Price: 41.64, Change: +2.39, Percent Change: +6.08
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SEI Price Prediction: Can SEI Rally From $0.06 to $1?
Japanese life insurance companies plan to increase holdings of Japanese government bonds, and demand for super-long-term JGBs is expected to improve.
Japan Post Insurance announced plans to increase its purchases of yen-denominated bonds, while Daido Life Insurance has raised its target for domestic bond holdings, focusing mainly on corporate bonds. Meiji Yasuda Life Insurance plans to keep its holdings of Japanese government bonds largely unchanged but will swap low-yield bonds for higher-yield varieties. This week, the 20-year government bond auction recorded a historic high bid-to-cover ratio, and life insurance institutions have been net buyers of super-long-term Japanese government bonds for four consecutive months.
Crypto prices
More
